Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
YI · Nasdaq · United States · Retail-Drug Stores And Proprietary Stores
In short111, Inc. is loss-making, generates cash and holds more cash than debt, with revenue shrinking (−12.8% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -0.0% | 17/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -0.5% | 18/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | – | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.09× | 24/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -0.07× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -5.72 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 0.9% | 24/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 24.6% | 20/100 |
| Operating margin volatility | 2.2% | 89/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -2.4% | 3/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CNY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 12,426 | 13,517 | 14,948 | 14,401 | 12,556 |
| Cost of revenue | 11,805 | 12,677 | 14,099 | 13,572 | 11,833 |
| Gross profit | 621 | 840 | 849 | 829 | 723 |
| Operating income | (642) | (371) | (350) | 2.1 | (2.4) |
| Interest expense | 5.5 | 13 | 20 | 28 | 36 |
| Pre-tax income | (621) | (376) | (353) | (21) | (23) |
| Income tax | 0 | 0 | 0.3 | 0.1 | 0 |
| Net income | (670) | (417) | (393) | (65) | (66) |
| Diluted EPS | −¥4.04 | −¥2.50 | −¥2.33 | −¥0.38 | −¥0.38 |
| Diluted shares (millions) | 166 | 167 | 169 | 172 | 174 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
−5.72 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Apr 30, 2026